pharmaceutical

• IRS Audits Google’s Profit Moves

  By Jesse Drucker, Bloomberg  |  October 13, 2011

  Agency looks at how company avoided taxes by shifting profits to offshore subsidiaries.

• Transfer-Pricing Crackdown

  By Dave Lindorff  |  May 2, 2011

  Governments closely scrutinize company transactions.

• Defensive Tactics in China

  By John Hintze  |  March 1, 2011

  U.S companies that source products in China are looking for ways to cope with higher production costs.

• Financial Executives: Keeping Track

  By Hilary Johnson  |  December 2, 2010

  Mark Guinan; Dennis Vigneau; James Mead; Sarah Stashak; Steve Cave; Jamie Caulfield; Anthony James

• Trading on Their Own

  By John Hintze  |  September 2, 2010

  Big companies are still the ones most likely to execute trades in-house, even though new technology has made it easier to set up a trading desk.

• Financial Executives: Keeping Track

  By Staff Writer  |  August 2, 2010

  Douglas Braunstein; Robert Biglin; Robert Hombach; John Thomas III; Eric Hession; Michael Lucareli; Maximiliane Straub; Mitchell Butier; Alan Haughie; Sachin Mehra; Michael Neborak; Brandon Pedersen

• Financial Executives: Keeping Track

  By Staff Writer  |  June 1, 2010

  Charles Noski; Edward Rapp; Charles Bancroft; Irene Esteves; Dilek Samil; Jeff Knobel

• Careers

  By Staff Writer  |  April 1, 2010

  William Weideman; Jason Aiken; Christopher Swift; Jeff Agosta; David Turner; John Sheehan

• CFOs to Watch: Ready for Opportunity

  By Richard Gamble  |  January 5, 2010

  Emerging as winners after the financial crisis, three CFOs--Ford Motor's Lewis Booth, Platinum Equity's Mary Ann Sigler and Merck's Peter Kellogg--aim to thrive in the new normal.